trial

Deep Brain Stimulation of the Nucleus Accumbens and Anterior Limb of the Internal Capsule in the Treatment of Refractory Schizophrenia

NCTId NCT07369401
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Not Yet Recruiting
Enrollment 10 (estimated)
Sponsored by First Affiliated Hospital of Fujian Medical University
Primary completion 2026-12-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Not Yet Recruiting
Enrollment
10 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2026-01-20
Primary completion
2026-12-31
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
Deep brain stimulation

Sponsors

First Affiliated Hospital of Fujian Medical UniversityLead Sponsor

Sites

0 total

Facts & assertions

4 sourced
Enrollment
10
Phase
NA
Primary Completion Date
2026-12-31
Status
NOT_YET_RECRUITING
relationships
The graph out of here
drug
Deep brain stimulation
drug
lead_sponsor
First Affiliated Hospital of Fujian Medical University
company
indication
Refractory Schizophrenia
indication
Schizophrenia, Treatment-Resistant
indication